Pfizer’s Litfulo is already approved in alopecia areata; however, the success of the TRANQUILLO programme sets it up for potential approval in NSV.
The tool’s selection comes shortly after the EDPB released guidelines for clinical trial data anonymisation.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Combine proprietary data, human expertise, and purpose-built AI to uncover insights and accelerate better business decisions.
Discover our solutions
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Keeping pace with generative AI in pharmaceutical and healthcare organisations
How wearables can unlock their full potential in clinical research
Clinical trial experts cite trust and regulatory uncertainty as AI barriers
Kidney disease risk higher after Covid infection than after influenza infection